Skip to main content
Fig. 1 | Human Genomics

Fig. 1

From: Mendelian randomization and colocalization analysis reveal novel drug targets for myasthenia gravis

Fig. 1

Overview of the study design. Promising drug targets are identified by multiple steps including eQTL MR, sensitivity, colocalization, pQTL MR analysis, ELISA, clinical trial review, and safety evaluation. eQTL, expression quantitative trait loci; pQTL, protein quantitative trait loci; MR, mendelian randomization; MG, myasthenia gravis; IMGGC, International Myasthenia Gravis Genomics Consortium; PPI, protein-protein interaction

Back to article page

Human Genomics

ISSN: 1479-7364